Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Gordonmd Global Investments L.P.
BioCentury | Aug 3, 2023
Finance
Aug. 3 Quick Takes: Kyverna extends B round to $145M
Plus: Aravive low on cash after ovarian cancer miss, Agios to develop Alnylam program, and updates from Seagen and Amber
BioCentury | Mar 30, 2022
Emerging Company Profile
SalioGen: genome editing without viruses or nucleases
The Cambridge, Mass.-based biotech is using mammalian enzymes to insert DNA into the genome without causing breaks
BioCentury | Oct 12, 2021
Management Tracks
Novartis’ Baert joins Flagship
Plus: MacKenzie retiring from Pfizer, Ipsen, Ensoma, ChemoCentryx and more
Items per page:
1 - 3 of 3